Clinical Trial Update: Selective Serotonin Reuptake Inhibitors (SSRIs) in Borderline Personality Disorder [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating selective serotonin reuptake inhibitors for Borderline Personality Disorder was terminated, with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Borderline Personality Disorder

Snippet

Sponsor: University of Chicago | Conditions: Borderline Personality Disorder | Phase 2 | Status: TERMINATED | Results posted: 2019-06-14